Author(s): Xing H, Hwang K, Li J, Torabi SF, Lu Y
Abstract Share this page
Abstract This review highlights recent progress in developing DNA aptamers for personalized medicine, with more focus on in vivo studies for potential clinical applications. Examples include design of aptamers in combination with DNA nanostructures, nanomaterials, or microfluidic devices as diagnostic probes or therapeutic agents for cancers and other diseases. The use of aptamers as targeting agents in drug delivery is also covered. The advantages and future directions of such DNA aptamer-based technology for the continued development of personalized medicine are discussed.
This article was published in Curr Opin Chem Eng
and referenced in Journal of Molecular Biomarkers & Diagnosis